IPOPI - PiNSA Members

Sub-Q IG Administration-Freedom60 Pump

info@pinsa.org.za — Thu, 10 Apr 2025 18:01:49 +0000

Sub-Q IG Administration-Freedom60 Pump

The post Sub-Q IG Administration-Freedom60 Pump first appeared on PiNSA Members.

D3 S12 – Martine Pergent – Rafael Graca – IPOPI GLM 2024

PiNSA — Sun, 23 Feb 2025 11:48:25 +0000

D3 S12 – Dr Nizar Mahlaoui – IPOPI GLM 2024

PiNSA — Sun, 23 Feb 2025 11:48:19 +0000

D3 S12 – Dr Garcelon – IPOPI GLM 2024

PiNSA — Sun, 23 Feb 2025 11:48:16 +0000

D3 S11 – Prof Sanchez Ramon – IPOPI GLM 2024

PiNSA — Sun, 23 Feb 2025 11:48:10 +0000

D3 S10 – Ms Toya Al – IPOPI GLM 2024

PiNSA — Sun, 23 Feb 2025 11:48:07 +0000

D3 S10 – Dr Hews Gerarad – IPOPI GLM 2024

PiNSA — Sun, 23 Feb 2025 11:48:03 +0000

D2 S6 – Prof Suarez – IPOPI GLM 2024

PiNSA — Sun, 23 Feb 2025 11:48:00 +0000

D2 S6 – Dr Riviere – IPOPI GLM 2024

PiNSA — Sun, 23 Feb 2025 11:47:57 +0000

D2 S6 – Dr Dalm – IPOPI GLM 2024

PiNSA — Sun, 23 Feb 2025 11:47:53 +0000

D2 S5 – Prof Candotti – IPOPI GLM 2024

PiNSA — Sun, 23 Feb 2025 11:47:50 +0000

D1 S1 – Prof Holland – IPOPI GLM 2024

PiNSA — Sun, 23 Feb 2025 11:27:51 +0000

X-Linked Agammaglobulinaemia

PiNSA — Thu, 16 Mar 2023 10:38:38 +0000

Wiskott-Aldrich-Syndrome

PiNSA — Thu, 16 Mar 2023 10:32:48 +0000

CGD Chronic Granulomatous Disease

PiNSA — Thu, 16 Mar 2023 10:21:44 +0000

Severe combined immunodeficiency

PiNSA — Thu, 16 Mar 2023 10:06:54 +0000

Autoimmunity

PiNSA — Thu, 16 Mar 2023 10:01:52 +0000

Common Variable Immunodeficiency

PiNSA — Thu, 16 Mar 2023 09:59:22 +0000

Chronic Granulomatous Disease

PiNSA — Thu, 16 Mar 2023 09:57:02 +0000

A Guide for Hepatologists

PiNSA — Sun, 12 Mar 2023 10:33:59 +0000

A Guide for General Practitioners

PiNSA — Sun, 12 Mar 2023 10:31:46 +0000

A Guide for Internal Medicine Specialists

PiNSA — Sun, 12 Mar 2023 10:28:03 +0000

PIDS and Gastrointestinal Disorders

PiNSA — Sun, 12 Mar 2023 10:25:30 +0000

Genetic diagnosis of PIDS

PiNSA — Sun, 12 Mar 2023 10:22:41 +0000

A Guide for Gastroenterologists

PiNSA — Sun, 12 Mar 2023 10:17:41 +0000

Primary immunodeficiencies and allergies

PiNSA — Sat, 11 Mar 2023 11:01:10 +0000

Primary immunodeficiencies and infections

PiNSA — Sat, 11 Mar 2023 10:57:20 +0000

Primary immunodeficiencies and psychological management

PiNSA — Sat, 11 Mar 2023 09:51:33 +0000

CVID management

PiNSA — Sat, 11 Mar 2023 09:34:07 +0000

Value of SCID newborn screening

PiNSA — Sat, 11 Mar 2023 09:29:32 +0000

APDS – Activated PI3K Delta syndrome

PiNSA — Sat, 11 Mar 2023 09:20:51 +0000

Ataxia Telangiectasia

PiNSA — Sat, 11 Mar 2023 09:14:52 +0000

Hyper-IgE Syndrome

PiNSA — Sat, 11 Mar 2023 09:12:49 +0000

WHIM Syndrome

PiNSA — Sat, 11 Mar 2023 09:06:42 +0000

Essentials of PID Diagnosis

PiNSA — Sat, 11 Mar 2023 09:04:15 +0000

Rheumatological, Autoimmune and Autoinflammatory Crossovers

PiNSA — Sat, 11 Mar 2023 09:00:22 +0000

Targeted Therapies for PIDs

PiNSA — Sat, 11 Mar 2023 08:56:15 +0000

X-linked Agammaglobulinaemia (XLA)

PiNSA — Sat, 11 Mar 2023 08:54:14 +0000

Wiskott-Aldrich Syndrome (WAS)

PiNSA — Sat, 11 Mar 2023 08:50:40 +0000

Chronic Granulomatous Disease (CGD)

PiNSA — Sat, 11 Mar 2023 08:47:41 +0000

Diagnosis of Primary Immunodeficiencies

PiNSA — Fri, 10 Mar 2023 13:26:34 +0000

Genetic Diagnosis of PIDS

PiNSA — Fri, 10 Mar 2023 13:21:40 +0000

Primary Immunodeficiency and cancer

PiNSA — Fri, 10 Mar 2023 13:14:26 +0000

PIDS and the Skin

PiNSA — Fri, 10 Mar 2023 12:57:26 +0000

IPOPI POSITION STATEMENT Access to Immunoglobulin Therapies for patients living with a Primary Immunodeficiency 2012

PiNSA — Mon, 06 Mar 2023 12:00:26 +0000

IPOPI CONGRESS REPORT – BUDAPEST 2015

PiNSA — Thu, 17 Mar 2016 10:31:34 +0000

Find out about what transpired at the 2015 International Primary Immunodeficiency Congress with this detailed overview of the event.

The post IPOPI CONGRESS REPORT – BUDAPEST 2015 first appeared on PiNSA Members.

PINSA POSITION STATEMENT ON ACCESS TO IMMUNOGLOBULIN THERAPIES FOR PATIENTS LIVING WITH A PRIMARY IMMUNODEFICIENCY

PiNSA — Mon, 29 Sep 2014 18:48:52 +0000

July 2014 This PiNSA statement supports international calls to ensure access to the best suited immunoglobulin (IG) replacement therapy, as prescribed by physicians for patients living with a primary immunodeficiency (PID)[1] that requires IG replacement therapy. It is estimated that there are between 20,000- 40,000 South Africans living with PID, of whom 99% remain undiagnosed....

The post PINSA POSITION STATEMENT ON ACCESS TO IMMUNOGLOBULIN THERAPIES FOR PATIENTS LIVING WITH A PRIMARY IMMUNODEFICIENCY first appeared on PiNSA Members.

IPOPI POSITION STATEMENT Access to Immunoglobulin Therapies for patients living with a Primary Immunodeficiency

PiNSA — Mon, 29 Sep 2014 18:45:13 +0000

8 May 2012 This statement is intended to provide a summary of IPOPI’s position with regards to the importance of ensuring access for patients living with a primary immunodeficiency (PID) to the best suited immunoglobulin (IG) replacement therapy, as selected and prescribed by their physician. IPOPI is concerned by recent developments in several countries that...

The post IPOPI POSITION STATEMENT Access to Immunoglobulin Therapies for patients living with a Primary Immunodeficiency first appeared on PiNSA Members.